Detalhe da pesquisa
1.
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.
PLoS Pathog
; 18(10): e1010885, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36194628
2.
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
HIV Med
; 25(1): 95-106, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37670375
3.
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) study.
J Neurovirol
; 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38575831
4.
Understanding the conditions included in data-driven patterns of multimorbidity: a scoping review.
Eur J Public Health
; 34(1): 35-43, 2024 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37837614
5.
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Clin Infect Dis
; 76(2): 201-209, 2023 01 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36196614
6.
Cerebrospinal fluid virology in people with HIV.
HIV Med
; 24(7): 838-844, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36895097
7.
Anticholinergic medications associated with falls and frailty in people with HIV.
HIV Med
; 24(12): 1198-1209, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37644705
8.
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
HIV Med
; 24(2): 224-230, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35934954
9.
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
HIV Med
; 24(11): 1126-1136, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37849432
10.
Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study.
Clin Infect Dis
; 75(3): 493-502, 2022 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34747481
11.
Molecular neuroimaging of inflammation in HIV.
Clin Exp Immunol
; 210(1): 14-23, 2022 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35020855
12.
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
HIV Med
; 23(8): 849-858, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35338549
13.
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
J Neurovirol
; 28(1): 54-63, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34874540
14.
Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward.
Clin Infect Dis
; 73(6): 1113-1118, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33904889
15.
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Clin Infect Dis
; 73(1): 50-59, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34370842
16.
Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individuals.
AIDS Care
; 33(10): 1296-1307, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33356492
17.
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
J Neurovirol
; 26(5): 754-763, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32500477
18.
The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
Biomed Chromatogr
; 34(1): e4711, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31629375
19.
Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus-positive Patients Treated With Protease Inhibitor Monotherapy.
Clin Infect Dis
; 68(6): 1031-1040, 2019 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30084882
20.
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.
Clin Infect Dis
; 68(4): 597-606, 2019 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29912307